Business Breaking News Biotron positive after phase 2 trial
15 minutes ago
AAP
Biotron positive after phase 2 trial
Biotron has received positive results from its phase 2 study of antiviral drug BIT225, with the number of Hepatitis C patients recovering much higher.
The drug was safe and well-tolerated and provides key data on the performance of the capsule formulation.
The company will look to use this data for an upcoming phase 2 trial on HIV-1 patienrs, starting mid-2016. The above article appeared on Perth Now's website this morning. FYI